Agios Pharmaceutical (AGIO)

Agios Pharmaceutical (AGIO) losing ground after releasing final data from multiple Phase 1 studies. Results from several studies were positive, paving the way for further study and drug development. In spite of positive news, AGIO continues to slide on heavy volume (650,000 shares traded an hour into the session versus average daily volume of 463,000) as potential profit takers swing in sell on the news. Options volume is moderate with the 06/19/2015 105.00 Put most actively traded with 308 contracts traded versus an open interest of 338 contracts. The Put/Call volume ratio is bearish with 3 Puts traded to every Call.

daily

weekly